Orphan Drugs Market Size, Trends, and Growth Strategies 2026-2033 The orphan drugs market is witnessing robust expansion driven by advancements in biotechnology and heightened focus on rare disease therapeutics. This industry is evolving rapidly, propelled by regulatory incentives and increasing R&D investments targeting niche patient populations, thereby reshaping the pharmaceutical landscape. Market Size and Overview The Global Orphan Drugs Market size is estimated to be valued at USD 175.4 billion in 2026 and is expected to reach USD 320.8 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2026 to 2033. https://www.coherentmarketinsights.com/market-insight/orphan-drugs-market-500